These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 15525639)
1. INSL5 is a high affinity specific agonist for GPCR142 (GPR100). Liu C; Kuei C; Sutton S; Chen J; Bonaventure P; Wu J; Nepomuceno D; Kamme F; Tran DT; Zhu J; Wilkinson T; Bathgate R; Eriste E; Sillard R; Lovenberg TW J Biol Chem; 2005 Jan; 280(1):292-300. PubMed ID: 15525639 [TBL] [Abstract][Full Text] [Related]
2. Relaxin-3, INSL5, and their receptors. Liu C; Lovenberg TW Results Probl Cell Differ; 2008; 46():213-37. PubMed ID: 18236022 [TBL] [Abstract][Full Text] [Related]
3. Relaxin-3/insulin-like peptide 5 chimeric peptide, a selective ligand for G protein-coupled receptor (GPCR)135 and GPCR142 over leucine-rich repeat-containing G protein-coupled receptor 7. Liu C; Chen J; Kuei C; Sutton S; Nepomuceno D; Bonaventure P; Lovenberg TW Mol Pharmacol; 2005 Jan; 67(1):231-40. PubMed ID: 15465925 [TBL] [Abstract][Full Text] [Related]
4. G-protein-coupled receptor (GPCR)-142 does not contribute to relaxin-3 binding in the mouse brain: further support that relaxin-3 is the physiological ligand for GPCR135. Sutton SW; Bonaventure P; Kuei C; Nepomuceno D; Wu J; Zhu J; Lovenberg TW; Liu C Neuroendocrinology; 2005; 82(3-4):139-50. PubMed ID: 16679775 [TBL] [Abstract][Full Text] [Related]
5. R3(BDelta23 27)R/I5 chimeric peptide, a selective antagonist for GPCR135 and GPCR142 over relaxin receptor LGR7: in vitro and in vivo characterization. Kuei C; Sutton S; Bonaventure P; Pudiak C; Shelton J; Zhu J; Nepomuceno D; Wu J; Chen J; Kamme F; Seierstad M; Hack MD; Bathgate RA; Hossain MA; Wade JD; Atack J; Lovenberg TW; Liu C J Biol Chem; 2007 Aug; 282(35):25425-35. PubMed ID: 17606621 [TBL] [Abstract][Full Text] [Related]
6. Pharmacological characterization of relaxin-3/INSL7 receptors GPCR135 and GPCR142 from different mammalian species. Chen J; Kuei C; Sutton SW; Bonaventure P; Nepomuceno D; Eriste E; Sillard R; Lovenberg TW; Liu C J Pharmacol Exp Ther; 2005 Jan; 312(1):83-95. PubMed ID: 15367576 [TBL] [Abstract][Full Text] [Related]
7. Recent progress in relaxin-3-related research. Liu C; Bonaventure P; Sutton SW; Chen J; Kuei C; Nepomuceno D; Lovenberg TW Ann N Y Acad Sci; 2005 May; 1041():47-60. PubMed ID: 15956687 [TBL] [Abstract][Full Text] [Related]
8. Identification of relaxin-3/INSL7 as a ligand for GPCR142. Liu C; Chen J; Sutton S; Roland B; Kuei C; Farmer N; Sillard R; Lovenberg TW J Biol Chem; 2003 Dec; 278(50):50765-70. PubMed ID: 14522967 [TBL] [Abstract][Full Text] [Related]
9. Identification of the domains in RXFP4 (GPCR142) responsible for the high affinity binding and agonistic activity of INSL5 at RXFP4 compared to RXFP3 (GPCR135). Zhu J; Kuei C; Sutton S; Kamme F; Yu J; Bonaventure P; Atack J; Lovenberg TW; Liu C Eur J Pharmacol; 2008 Aug; 590(1-3):43-52. PubMed ID: 18582868 [TBL] [Abstract][Full Text] [Related]
10. The evolution of the relaxin peptide family and their receptors. Wilkinson TN; Bathgate RA Adv Exp Med Biol; 2007; 612():1-13. PubMed ID: 18161477 [TBL] [Abstract][Full Text] [Related]
12. Coevolution of the relaxin-like peptides and their receptors. Wilkinson TN; Speed TP; Tregear GW; Bathgate RA Ann N Y Acad Sci; 2005 May; 1041():534-9. PubMed ID: 15956757 [TBL] [Abstract][Full Text] [Related]
13. Membrane receptors: structure and function of the relaxin family peptide receptors. Kong RC; Shilling PJ; Lobb DK; Gooley PR; Bathgate RA Mol Cell Endocrinol; 2010 May; 320(1-2):1-15. PubMed ID: 20138959 [TBL] [Abstract][Full Text] [Related]
14. Identification of relaxin-3/INSL7 as an endogenous ligand for the orphan G-protein-coupled receptor GPCR135. Liu C; Eriste E; Sutton S; Chen J; Roland B; Kuei C; Farmer N; Jörnvall H; Sillard R; Lovenberg TW J Biol Chem; 2003 Dec; 278(50):50754-64. PubMed ID: 14522968 [TBL] [Abstract][Full Text] [Related]
15. Synthesis, conformation, and activity of human insulin-like peptide 5 (INSL5). Akhter Hossain M; Bathgate RA; Kong CK; Shabanpoor F; Zhang S; Haugaard-Jönsson LM; Rosengren KJ; Tregear GW; Wade JD Chembiochem; 2008 Jul; 9(11):1816-22. PubMed ID: 18576448 [TBL] [Abstract][Full Text] [Related]
16. Receptors for relaxin family peptides. Bathgate RA; Ivell R; Sanborn BM; Sherwood OD; Summers RJ Ann N Y Acad Sci; 2005 May; 1041():61-76. PubMed ID: 15956688 [TBL] [Abstract][Full Text] [Related]
17. Evolution of the signaling system in relaxin-family peptides. Hsu SY; Semyonov J; Park JI; Chang CL Ann N Y Acad Sci; 2005 May; 1041():520-9. PubMed ID: 15956755 [TBL] [Abstract][Full Text] [Related]
18. Distribution of G-protein-coupled receptor (GPCR)135 binding sites and receptor mRNA in the rat brain suggests a role for relaxin-3 in neuroendocrine and sensory processing. Sutton SW; Bonaventure P; Kuei C; Roland B; Chen J; Nepomuceno D; Lovenberg TW; Liu C Neuroendocrinology; 2004; 80(5):298-307. PubMed ID: 15677880 [TBL] [Abstract][Full Text] [Related]
19. Identification of important residues of insulin-like peptide 5 and its receptor RXFP4 for ligand-receptor interactions. Wang XY; Guo YQ; Shao XX; Liu YL; Xu ZG; Guo ZY Arch Biochem Biophys; 2014 Sep; 558():127-32. PubMed ID: 25043977 [TBL] [Abstract][Full Text] [Related]
20. Probing the functional domains of relaxin-3 and the creation of a selective antagonist for RXFP3/GPCR135 over relaxin receptor RXFP1/LGR7. Liu C; Kuei C; Sutton S; Shelton J; Zhu J; Nepomuceno D; Hossain MA; Wade JD; Bathgate RA; Bonaventure P; Lovenberg T Ann N Y Acad Sci; 2009 Apr; 1160():31-7. PubMed ID: 19416155 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]